Humana faces significant earnings headwinds due to CMS reforms, star rating downgrades, and potential Medicaid clawbacks.

The changes would limit how insurers add patient diagnoses that trigger lucrative extra payments.

Humana (HUM) backs reforms on extra Medicare Advantage payments from home visits and chart review. Read more here.

The health insurer has suffered mounting problems and backlash since the fatal shooting of former CEO Brian Thompson.

UnitedHealth Group Incorporated’s UNH new CEO, Steve Hemsley, began his return to leadership by issuing a rare apology to ...

The tech-heavy Nasdaq Composite rallied more than 9% this month. Information technology stocks are the top-performing sector ...

SelectQuote Inc. faced renewed investor pressure on Monday, May 12, 2025, as its shares tumbled another 12% following the release of quarterly results that fell short of earnings and revenue ...

Highmark Health recorded $13 million in net income during the first quarter, down from a $194 million a year before.

Humana (NYSE:HUM) recently reported first-quarter earnings, showcasing a revenue increase from USD 29,611 million to USD 32,112 million and a net income rise from USD 741 million to USD 1,244 million.

Stock losses accelerated Wednesday afternoon as US chip software designers plunged when the Financial Times reported that President Trump told a group of US companies offering software to design ...

Stock indexes today gave up an early advance and turned lower as an increase in bond yields undercut support for equities.  The 10-year T-note yield today is up +5 bp at 4.49%.  Stocks today initially ...

Major indices were little changed early on Wednesday as market participants awaited the release of minutes from the Federal ...